New information for vaccine manufacturers

A new process came into effect on 1 July 2020 for sponsors to request advice from ATAGI for vaccines to be listed on the National Immunisation Program.

Date published:
Audience:
General public

Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from the Australian Technical Advisory Group on Immunisation (ATAGI) before making a submission to the Pharmaceutical Benefits Advisory Committee (PBAC).

A new process for requesting this advice is now in effect.  

Vaccine manufacturers can contact the ATAGI secretariat with any questions about these arrangements.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.